Reclast (generic: zoledronic acid) is indicated for the prevention of osteoporosis and numerous complications that affect bone mass density. Unfortunately, Reclast may increase an individuals risk of developing severe, life-threatening side effects like atypical femur fractures and osteonecrosis of the jaw (ONJ).
Reclast lawsuit update: According to a U.S. Food and Drug Administration (FDA) Safety Communication, the agency has approved an update to the drug label for Reclast to better inform healthcare professionals and patients of an increased risk ofReclast kidney failure.
If you or a loved one has been injured by Reclast, you should contact our lawyersimmediately for a free confidential case evaluation. You may be entitled to compensation for your injuries and we can help.
What’s the problem?
A product of Novartis A.G., Reclast was developed as a prescription bisphosphonate treatment for osteoporosis, hypocalcemia, and numerous degenerative bone complications. As a bisphosphonate, Reclast aids in the natural process of homeostasis. During this process, bone naturally diminishes and is kept in balance by osteoblasts that generate new bone. In patients with osteoporosis, bone dexterity is diminished at a more rapid rate than it is generated. As a bisphosphonate, Reclast inhibits the breakdown of bone by preventing the osteoclasts from destroying the bone any further. Therefore, Aclasta promotes steady bone growth.
Unfortunately, the use of bisphosphonates, like Reclast, has been linked to severe and debilitating conditions in patients. People who use Reclast may experience osteonecrosis of the jaw (ONJ), musculoskeletal pain and diminished bone dexterity that can lead to an increased rate of femur fractures. Due to the severity of these side effects, our Reclast lawyers are ready to help represent plaintiffs in their potential Reclast lawsuit.
Side Effects of Reclast
The following side effects are being evaluated for potential Reclast lawsuits:
- Low impact femur fractures
- Thigh bone fractures
- Osteonecrosis of the jaw (ONJ)
- Musculoskeletal pain
- Atypical femur fractures
- Subtrochanteric femur fractures
- Femoral shaft fractures
- Thigh deformity
- Leg shortening
Osteonecrosis of the Jaw
Osteonecrosis of the Jaw (ONJ) is often referred to by many other names like Jaw Death, Dead Jaw disease, or Bisphossy Jaw. ONJ is a disfiguring and disabling condition in which jaw bones suffer from literal bone death through infection and rotting. ONJ develops when the jaw fails to heal after minor trauma such as a tooth extraction that results in bone exposure. ONJ has also been linked to the use of Reclast.
Bisphosphonate Osteoporosis Medications
- Aclasta
- Actonel
- Aredia
- Bondronat
- Boniva
- Didronel
- Fosamax
- Fosavance
- Reclast
- Skelid
- Zometa
JAMA Study Links Bisphosphonates to Unusual Bone Fractures
On February 22, 2011, The Journal of the American Medical Association (JAMA), published an article titled “Long-Term Use of Bisphosphonates Increases Risk for Atypical Fractures”. This article describes the dangers associated with long term use of Bisphosphonates. Over time, the drug may increase the risk for atypical subtrochanteric or femoral shaft fractures in older patients. Furthermore, concerns have emerged that these drugs may inhibit bone restructuring, leading to unusual fractures.
Do I have a Reclast Lawsuit?
The trial lawyers at The Senators (Ret.) Firm, LLP have decades of experience navigating through complex legislative and regulatory issues and litigating high stakes cases all over the nation. Our law firm focuses on the representation of plaintiffs in Reclast lawsuits. We are currently accepting new cases in all 50 states.
Again, if you or a loved one has been injured by Reclast, you should contact our lawyers immediately by clicking the link below or calling toll free 1-(949) 557-5800. You may be entitled to compensation for your injuries and we can help.